What Is The Public Meeting?
The public meeting is a full-day live-streamed event (usually 6-8 hours):
- First, ICER presents our findings from the Evidence Report to a council* of experts in healthcare policy, medicine, and health economics, including those representing patient perspectives.
- Second, the council discusses the report and votes on the overall effectiveness of the therapy in question.
- Third, a panel of experts weigh in on any health policy concerns. Watch an example of the policy roundtable here.
When Is The Public Meeting?
The public meeting is held 8 months following the launch of the review, and a few weeks after we release the revised Evidence Report, which is the revised version of our report incorporating feedback we received during the public comment period.
How Can I Participate In The Public Meeting?
- Attend the public meeting virtually or in-person. Encourage other patient advocates to attend as well!
- Nominate yourself or another patient advocate to make an oral comment (ICER selects a few patients to make oral public comments). Unfortunately, not everyone can speak at the public meeting. We will try our best to accommodate your request.
Our Ongoing Research:
- Chemotherapy-Induced Neutropenia
- Diabetes: Type 2
- Hypertrophic Cardiomyopathy
- Myasthenia Gravis
Talk with us | Contact Yvette Venable, ICER’s Vice President of Patient Engagement at firstname.lastname@example.org
Share | your patient experience
Respond | to our work
Participate | in ICER’s public meeting
Empower | your community with evidence